Amsterdam, The Netherlands: First results from a phase III clinical trial of the combination drug, T-DM1, show that it significantly improves the length of time before the disease worsens in women with advanced HER2 positive ...
Sep 27, 2013
0
0
Clinical trial design for new cancer therapies has historically been focused on the tissue of origin of a tumor, but a paper from researchers at Memorial Sloan-Kettering Cancer Center published on September 26 in Nature Genetics ...
Sep 27, 2013
0
0
The drug combination of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil (elvitegravir fixed combination, trade name: Stribild) has been approved in Germany since May 2013 for the treatment of adults infected ...
Sep 20, 2013
0
0
(HealthDay)—New research suggests that patients with obsessive-compulsive disorder do better when they combine intensive "exposure therapy" with an antidepressant rather than taking a common two-drug combination.
Sep 11, 2013
0
0
The U.S. Food and Drug Administration has issued a positive review of a breast cancer drug from Roche that could soon become the first pharmaceutical option approved for treating early-stage disease before surgery.
Sep 10, 2013
0
0
Women with ectopic pregnancies could be spared surgery if they are treated with a lung cancer drug, a study suggests.
Sep 9, 2013
0
0
A University of Minnesota research team featuring researchers from the Institute for Molecular Virology, School of Dentistry and Center for Drug Design has developed a new delivery system for a combination of two FDA approved ...
Aug 30, 2013
0
0
An innovation created by Purdue University researchers could improve therapy selection for personalized cancer care by helping specialists better identify the most effective drug treatment combinations for patients.
Aug 16, 2013
0
0
Children with invasive bloodstream infections treated with a single antibiotic are just as likely to overcome their infections as those who get two-drug therapy, but at half the risk of drug-induced kidney damage, according ...
Aug 12, 2013
0
0
(Medical Xpress)—The combinations of anti-HIV drugs recommended for pregnant women do not appear in general to increase their children's risk for language delay, according to a study from a National Institutes of Health ...
Jul 19, 2013
0
0
